Mesoblast LtdNASDAQ:MESO
- LAST PRICE7.6000
- TODAY'S CHANGE (%)0.1800 (2.4259%)
- Bid / Lots7.1000/ 1
- Ask / Lots7.7000/ 1
- Open / Previous Close7.4600 / 7.4200
- Day Range
- 52 Week Range
- Volume154,852
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MESO |
|---|---|---|
| 09:32 ET | 850 | 7.46 |
| 09:34 ET | 2633 | 7.6287 |
| 09:38 ET | 1000 | 7.6291 |
| 09:41 ET | 100 | 7.62 |
| 09:43 ET | 450 | 7.63 |
| 09:45 ET | 2864 | 7.62 |
| 09:48 ET | 300 | 7.68 |
| 09:50 ET | 1125 | 7.7 |
| 09:52 ET | 256 | 7.675 |
| 09:54 ET | 200 | 7.69 |
| 09:57 ET | 6815 | 7.65 |
| 09:59 ET | 6889 | 7.57 |
| 10:06 ET | 740 | 7.57 |
| 10:08 ET | 570 | 7.6348 |
| 10:10 ET | 200 | 7.63 |
| 10:12 ET | 200 | 7.63 |
| 10:14 ET | 200 | 7.63 |
| 10:15 ET | 100 | 7.63 |
| 10:17 ET | 5299 | 7.63 |
| 10:19 ET | 300 | 7.63 |
| 10:24 ET | 400 | 7.63 |
| 10:28 ET | 500 | 7.63 |
| 10:33 ET | 800 | 7.55 |
| 10:37 ET | 150 | 7.56 |
| 10:39 ET | 1200 | 7.62 |
| 10:42 ET | 150 | 7.62 |
| 10:46 ET | 1100 | 7.553713 |
| 10:48 ET | 250 | 7.53 |
| 10:51 ET | 700 | 7.58 |
| 10:57 ET | 100 | 7.57 |
| 11:00 ET | 900 | 7.57 |
| 11:08 ET | 500 | 7.57 |
| 11:13 ET | 800 | 7.56 |
| 11:20 ET | 1000 | 7.57 |
| 11:22 ET | 100 | 7.5 |
| 11:24 ET | 2235 | 7.54 |
| 11:27 ET | 100 | 7.55 |
| 11:31 ET | 300 | 7.58 |
| 11:33 ET | 1000 | 7.57 |
| 11:40 ET | 1300 | 7.5068 |
| 11:47 ET | 100 | 7.57 |
| 11:49 ET | 2399 | 7.57 |
| 11:58 ET | 1100 | 7.59 |
| 12:02 ET | 1000 | 7.5793 |
| 12:03 ET | 100 | 7.5799 |
| 12:05 ET | 100 | 7.5799 |
| 12:07 ET | 100 | 7.5799 |
| 12:09 ET | 1100 | 7.58 |
| 12:12 ET | 100 | 7.58 |
| 12:14 ET | 866 | 7.6 |
| 12:21 ET | 411 | 7.59 |
| 12:23 ET | 2100 | 7.58 |
| 12:30 ET | 2979 | 7.605 |
| 12:36 ET | 390 | 7.58 |
| 12:41 ET | 800 | 7.58 |
| 12:43 ET | 1100 | 7.6 |
| 12:50 ET | 100 | 7.57 |
| 12:54 ET | 1976 | 7.625 |
| 12:56 ET | 511 | 7.6 |
| 12:59 ET | 6050 | 7.63 |
| 01:03 ET | 1100 | 7.65 |
| 01:08 ET | 300 | 7.65 |
| 01:17 ET | 1100 | 7.65 |
| 01:32 ET | 1100 | 7.65 |
| 01:33 ET | 580 | 7.625 |
| 01:35 ET | 300 | 7.65 |
| 01:37 ET | 25784 | 7.67 |
| 01:42 ET | 100 | 7.67 |
| 01:44 ET | 1595 | 7.61 |
| 01:53 ET | 793 | 7.635 |
| 01:57 ET | 1100 | 7.67 |
| 02:00 ET | 100 | 7.67 |
| 02:04 ET | 425 | 7.6699 |
| 02:09 ET | 1200 | 7.66 |
| 02:22 ET | 1100 | 7.66 |
| 02:26 ET | 100 | 7.625 |
| 02:27 ET | 1000 | 7.63 |
| 02:33 ET | 700 | 7.63 |
| 02:36 ET | 200 | 7.63 |
| 02:38 ET | 200 | 7.63 |
| 02:40 ET | 1870 | 7.64 |
| 02:42 ET | 100 | 7.63 |
| 02:44 ET | 200 | 7.63 |
| 02:45 ET | 400 | 7.63 |
| 02:56 ET | 1100 | 7.63 |
| 02:58 ET | 505 | 7.61 |
| 03:00 ET | 100 | 7.63 |
| 03:02 ET | 200 | 7.63 |
| 03:03 ET | 200 | 7.63 |
| 03:05 ET | 200 | 7.63 |
| 03:07 ET | 400 | 7.63 |
| 03:09 ET | 300 | 7.63 |
| 03:12 ET | 200 | 7.63 |
| 03:14 ET | 200 | 7.63 |
| 03:16 ET | 200 | 7.63 |
| 03:18 ET | 200 | 7.63 |
| 03:20 ET | 558 | 7.63 |
| 03:21 ET | 300 | 7.63 |
| 03:23 ET | 200 | 7.63 |
| 03:25 ET | 200 | 7.63 |
| 03:27 ET | 500 | 7.63 |
| 03:30 ET | 400 | 7.63 |
| 03:32 ET | 200 | 7.63 |
| 03:34 ET | 603 | 7.63 |
| 03:36 ET | 300 | 7.63 |
| 03:38 ET | 400 | 7.63 |
| 03:39 ET | 6246 | 7.64 |
| 03:41 ET | 100 | 7.64 |
| 03:43 ET | 300 | 7.64 |
| 03:45 ET | 680 | 7.64 |
| 03:48 ET | 200 | 7.64 |
| 03:50 ET | 500 | 7.64 |
| 03:52 ET | 300 | 7.64 |
| 03:56 ET | 882 | 7.64 |
| 03:57 ET | 9198 | 7.64 |
| 03:59 ET | 8192 | 7.6 |
Sep 24, 2024
DJ Mesoblast Raised to Buy From Hold by Maxim Group, from 9:12AM ET on Tuesday Sep 24, 2024 by Dow Jones
9:12AM ET on Tuesday Sep 24, 2024 by Dow Jones
Aug 29, 2024
DJ Mesoblast Raised to Buy From Hold by Jefferies, from 11:37AM ET on Thursday Aug 29, 2024 by Dow Jones
11:37AM ET on Thursday Aug 29, 2024 by Dow Jones*DJ Mesoblast Upgraded to Buy from Hold by Jefferies, from 1:43AM ET on Thursday Aug 29, 2024 by Dow Jones
1:43AM ET on Thursday Aug 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mesoblast Ltd | 704.1M | -8.7x | --- |
SS Innovations International Inc | 677.8M | -26.9x | --- |
Oric Pharmaceuticals Inc | 697.7M | -6.0x | --- |
MBX Biosciences Inc | 713.1M | -16.2x | --- |
Rapport Therapeutics Inc | 695.0M | -12.1x | --- |
IGM Biosciences Inc | 729.6M | -4.6x | --- |
Company Information
Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.
Contact Information
- Headquarters
- L 38 55 Collins StMELBOURNE, VIC, Australia 3000
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Jane Bell
- Chief Executive Officer, Executive Director
- Silviu Itescu
- Non-Executive Independent Vice Chairman of the Board
- William Burns
- Interim Chief Financial Officer
- Andrew Chaponnel
- Chief Operating Officer
- Dagmar Rosa-Bjorkeson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $704.1M |
|---|---|
Revenue (TTM) | $5.9M |
Shares Outstanding | 114.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.47 |
EPS | $-0.88 |
Book Value | $4.21 |
P/E Ratio | -8.7x |
Price/Sales (TTM) | 119.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,173.11% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
